Top Markets
#1 Black Phoenix Black Phoenix +828.22%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.74%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.29%
#4 Bless Bless +21.01%
#5 SAFEcoin SAFEcoin +20.57%
#6 pipedog pipedog +20.53%
#7 Magma Finance Magma Finance +20.34%
#8 PondCoin PondCoin +20.03%
#9 Beam Beam +19.60%
#10 YFSX YFSX +16.01%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Rang in Aktien #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Aktienkurs
$45.79
Marktkapitalisierung
$2.33B
Veränderung (1 Tag)
11.43%
Veränderung (1 Jahr)
408.10%
Land
FR
Handel Nanobiotix S.A. (NANO)

Kategorie

Healthcare
Dividendenhistorie für Nanobiotix S.A. (NANO)
Nanobiotix S.A. (Aktienkürzel: NANO) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Nanobiotix S.A. (NANO) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH